MWM
LABD icon

Meridian Wealth Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Meridian Wealth Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-848
Closed -$203K – 534
2022
Q3 		$203K Hold
848
– – 0.02% 453
2022
Q2 		$330K Buy
+848
New +$425K 0.03% 426

Other funds holding LABD

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meridian Wealth Management's LABD Position: Q4 2022 in Review

Meridian Wealth Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2022, closing a stake of 848 shares — an estimated $203K sold.

Meridian Wealth Management first reported a position in LABD in Q2 2022 and held it in 2 quarters. The position peaked at $330K in Q2 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2022.

  • Meridian Wealth Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2022 after selling out during the quarter.
  • Meridian Wealth Management sold 848 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2022, an estimated $203K.
  • Meridian Wealth Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2022 and held it in 2 quarters.
  • Meridian Wealth Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $330K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2022.

Based on Meridian Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.